
Shares of specialty chemicals maker Celanese CE.N rise 10.6% to $39.95
Co reports Q3 adj EPS of $1.34, beating estimates of $1.22 -LSEG data
Co says it remains on track to generate $700 million to $800 million in free cash flow in 2025
Brokerage Baird says CE's strong internal execution through cost reductions and working capital optimization positions them to meet their FCF target, providing stability despite global economic challenges.
However, Q3 revenue of 2.42 billion, misses estimates of $2.51 billion
Co forecasts Q4 adj EPS also below expectations
Six of 17 brokerages rate the stock "buy" or higher, nine "hold" and two "sell" or lower; their median PT is $51
Including session's moves, stock had fallen 47.8% YTD